These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7592173)

  • 21. Nalidixic acid-resistant mutations of the gyrB gene of Escherichia coli.
    Yamagishi J; Yoshida H; Yamayoshi M; Nakamura S
    Mol Gen Genet; 1986 Sep; 204(3):367-73. PubMed ID: 3020376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of R-factors on the sensitivity of Shigella sonnei to nalidixic acid].
    Sivolodskii EP
    Antibiotiki; 1976 Dec; 21(12):1085-9. PubMed ID: 798548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of R plasmids on the growth characteristics of Shigella sonnei and Escherichia coli].
    Medzhidov MM; Adzhieva AA; Moroz AF; Terekhov AA
    Antibiot Med Biotekhnol; 1985 Oct; 30(10):757-60. PubMed ID: 3911872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fosfomycin and plasmidic resistance.
    Baquero F; López-Brea M; Valls A; Cañedo T
    Chemotherapy; 1977; 23 Suppl 1():133-40. PubMed ID: 318973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival of recombination-deficient mutants of Escherichia coli during incubation with nalidixic acid.
    McDaniel LS; Rogers LH; Hill WE
    J Bacteriol; 1978 Jun; 134(3):1195-8. PubMed ID: 350844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of nalidixic acid and hydroxyurea on division ability of Escherichia coli fil+ and lon- strains.
    Kantor GJ; Deering RA
    J Bacteriol; 1968 Feb; 95(2):520-30. PubMed ID: 4867744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of a nalidixic-acid-resistant mutant of Escherichia coli as a strict aerobe.
    Yoshizawa Y; Yamamoto N
    Microbiol Immunol; 1989; 33(6):449-57. PubMed ID: 2549346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repair and plasmid R46 mediated mutation requires inducible functions in Proteus mirabilis.
    Hofemeister J; Eitner G
    Mol Gen Genet; 1981; 183(2):369-75. PubMed ID: 7035831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of plasmid conjugation by some recently synthetized 4-quinolone compounds.
    Scazzocchio F; Selan L; Oliva B; Schippa S; Cellini L; Renzini G
    Chemioterapia; 1988 Oct; 7(5):295-7. PubMed ID: 3066516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibiotic residues and R-plasmid selection: are in vitro methods good models?
    Corpet DE; Lumeau S
    Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Apr; 264(1-2):178-84. PubMed ID: 3307231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of R-factor plasmids on host-cell responses to nalidixic acid I. Increased susceptibility of nalidixic acid-sensitive hosts.
    Crumplin GC; Smith JT
    J Antimicrob Chemother; 1981 Apr; 7(4):379-88. PubMed ID: 7019186
    [No Abstract]   [Full Text] [Related]  

  • 32. In vivo selection during ofloxacin therapy of Escherichia coli with combined topoisomerase mutations that confer high resistance to ofloxacin but susceptibility to nalidixic acid.
    Cattoir V; Lesprit P; Lascols C; Denamur E; Legrand P; Soussy CJ; Cambau E
    J Antimicrob Chemother; 2006 Nov; 58(5):1054-7. PubMed ID: 16984897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nalidixic acid inhibits the conjugal transfer of conjugative N incompatibility group plasmids.
    Gill S; Iyer VN
    Can J Microbiol; 1982 Feb; 28(2):256-8. PubMed ID: 7039791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nalidixic acid-resistant auxotrophs of Escherichia coli.
    Helling RB; Adams BS
    J Bacteriol; 1970 Nov; 104(2):1027-9. PubMed ID: 4923064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transfer of the IncJ plasmid R391 to recombination deficient Escherichia coli K12: evidence that R391 behaves as a conjugal transposon.
    Murphy DB; Pembroke JT
    FEMS Microbiol Lett; 1995 Dec; 134(2-3):153-8. PubMed ID: 8586262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mode of incomplete cross-resistance among pipemidic, piromidic, and nalidixic acids.
    Inoue S; Ohue T; Yamagishi J; Nakamura S; Shimizu M
    Antimicrob Agents Chemother; 1978 Aug; 14(2):240-5. PubMed ID: 358918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quinolone action in Escherichia coli cells carrying gyrA and gyrB mutations.
    Herrera G; Aleixandra V; Urios A; Blanco M
    FEMS Microbiol Lett; 1993 Jan; 106(2):187-91. PubMed ID: 8384139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Escherichia coli K-12 mutants resistant to nalidixic acid: genetic mapping and dominance studies.
    Hane MW; Wood TH
    J Bacteriol; 1969 Jul; 99(1):238-41. PubMed ID: 4895844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Habituation to acid in Escherichia coli: conditions for habituation and its effects on plasmid transfer.
    Raja N; Goodson M; Chui WC; Smith DG; Rowbury RJ
    J Appl Bacteriol; 1991 Jan; 70(1):59-65. PubMed ID: 1707869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Types of spontaneous nalidixic acid resistant mutants of Escherichia coli.
    Kumar S
    Indian J Exp Biol; 1980 Apr; 18(4):341-3. PubMed ID: 6995285
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.